Literature DB >> 26892969

The Success Story of LDL Cholesterol Lowering.

Terje R Pedersen1.   

Abstract

We can look back at >100 years of cholesterol research that has brought medicine to a stage where people at risk of severe or fatal coronary heart disease have a much better prognosis than before. This progress has not come about without resistance. Perhaps one of the most debated topics in medicine, the cholesterol controversy, could only be brought to rest through the development of new clinical research methods that were capable of taking advantage of the amazing achievements in basic and pharmacological science after the second World War. It was only after understanding the biochemistry and physiology of cholesterol synthesis, transport and clearance from the blood that medicine could take advantage of drugs and diets to reduce the risk of atherosclerotic diseases. This review points to the highlights of the history of low-density lipoprotein-cholesterol lowering, with the discovery of the low-density lipoprotein receptor and its physiology and not only the development of statins as the stellar moments but also the development of clinical trial methodology as an effective tool to provide scientifically convincing evidence.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  atherosclerosis; cholesterol, LDL; coronary artery disease; primary prevention; secondary prevention

Mesh:

Substances:

Year:  2016        PMID: 26892969     DOI: 10.1161/CIRCRESAHA.115.306297

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  11 in total

1.  Reducing exposure to cardiovascular risk factors: the legacy of prevention.

Authors:  Benoit J Arsenault; Rishi Puri
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

2.  Atherosclerosis: Successes, Surprises, and Future Challenges.

Authors:  Peter Libby; Karin E Bornfeldt; Alan R Tall
Journal:  Circ Res       Date:  2016-02-19       Impact factor: 17.367

3.  Combined Effects of Plant Sterols with Low Ratio of n-6/n-3 Polyunsaturated Fatty Acids against Atherosclerosis in ApoE-/- Mice.

Authors:  Chen Chen; Li Lu; Ya-Ting Qin; Chao Lv; Xiao-Ning Wan; Xiao-Mei Guo
Journal:  Curr Med Sci       Date:  2021-01-11

Review 4.  The advantageous role of annexin A1 in cardiovascular disease.

Authors:  Renske de Jong; Giovanna Leoni; Maik Drechsler; Oliver Soehnlein
Journal:  Cell Adh Migr       Date:  2016-11-18       Impact factor: 3.405

Review 5.  It's reticulated: the liver at the heart of atherosclerosis.

Authors:  Prabhakara R Nagareddy; Sunil K Noothi; Michelle C Flynn; Andrew J Murphy
Journal:  J Endocrinol       Date:  2018-05-02       Impact factor: 4.286

Review 6.  Fibrates Revisited: Potential Role in Cardiovascular Risk Reduction.

Authors:  Nam Hoon Kim; Sin Gon Kim
Journal:  Diabetes Metab J       Date:  2020-04       Impact factor: 5.376

7.  Identification of Proteins Interacting with PCSK9 Using a Protoarray Human Protein Microarray.

Authors:  Catherine J Wooten; Sreevidhya T Krishnaji; Quantil M Melendez; Dayami Lopez
Journal:  Int J Biomed Investig       Date:  2019-09-18

8.  A trans-omic Mendelian randomization study of parental lifespan uncovers novel aging biology and therapeutic candidates for chronic diseases.

Authors:  Nicolas Perrot; William Pelletier; Jérôme Bourgault; Christian Couture; Zhonglin Li; Patricia L Mitchell; Nooshin Ghodsian; Yohan Bossé; Sébastien Thériault; Patrick Mathieu; Benoit J Arsenault
Journal:  Aging Cell       Date:  2021-10-27       Impact factor: 9.304

Review 9.  Icariin, an Anti-atherosclerotic Drug from Chinese Medicinal Herb Horny Goat Weed.

Authors:  Jian Fang; Yongjun Zhang
Journal:  Front Pharmacol       Date:  2017-10-12       Impact factor: 5.810

Review 10.  Working towards full eradication of lipid-driven cardiovascular risk?

Authors:  N S Nurmohamed; E S G Stroes
Journal:  Neth Heart J       Date:  2021-07-19       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.